Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-(5-amino-4-(3-cyanobenzoyl)-1h-pyrazol-1-yl)-n-cyclopropyl-4-methylbenzamide
2. Benzamide, 3-(5-amino-4-(3-cyanobenzoyl)-1h-pyrazol-1-yl)-n-cyclopropyl-4-methyl-
1. 836683-15-9
2. Acumapimod (bct-197)
3. Acumapimod [inn]
4. 3-(5-amino-4-(3-cyanobenzoyl)-1h-pyrazol-1-yl)-n-cyclopropyl-4-methylbenzamide
5. Bct-197
6. 2f16kw647l
7. 3-(5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl)-n-cyclopropyl-4-methylbenzamide
8. 3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide
9. Benzamide, 3-(5-amino-4-(3-cyanobenzoyl)-1h-pyrazol-1-yl)-n-cyclopropyl-4-methyl-
10. Unii-2f16kw647l
11. Acumapimod [who-dd]
12. Bct197
13. Gtpl9203
14. Schembl1382253
15. Bct 197
16. Bcp29101
17. Ex-a1450
18. Compound A [wo2013139809]
19. Mfcd28902244
20. Zinc116024237
21. Cs-6195
22. Db15448
23. Sb18669
24. Ac-36221
25. Hy-16715
26. D84042
27. A915163
28. Q27074309
29. 3-[5-amino-4-(3-cyano-benzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methyl-benzamide
30. 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide
| Molecular Weight | 385.4 g/mol |
|---|---|
| Molecular Formula | C22H19N5O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 385.15387487 g/mol |
| Monoisotopic Mass | 385.15387487 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 684 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
100
PharmaCompass offers a list of Acumapimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acumapimod manufacturer or Acumapimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acumapimod manufacturer or Acumapimod supplier.
PharmaCompass also assists you with knowing the Acumapimod API Price utilized in the formulation of products. Acumapimod API Price is not always fixed or binding as the Acumapimod Price is obtained through a variety of data sources. The Acumapimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Acumapimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acumapimod, including repackagers and relabelers. The FDA regulates Acumapimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acumapimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acumapimod supplier is an individual or a company that provides Acumapimod active pharmaceutical ingredient (API) or Acumapimod finished formulations upon request. The Acumapimod suppliers may include Acumapimod API manufacturers, exporters, distributors and traders.
Acumapimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acumapimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acumapimod GMP manufacturer or Acumapimod GMP API supplier for your needs.
A Acumapimod CoA (Certificate of Analysis) is a formal document that attests to Acumapimod's compliance with Acumapimod specifications and serves as a tool for batch-level quality control.
Acumapimod CoA mostly includes findings from lab analyses of a specific batch. For each Acumapimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acumapimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Acumapimod EP), Acumapimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acumapimod USP).
